Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latuda in Acutely Psychotic Schizophrenia
NCT01821378Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- May 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Sumitomo Pharma America. Started May 2013; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01821378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821378.